Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Levan J. Lezhava"'
Autor:
John E. Hearst, David L. Jaye, Sabina A. Alexander, Levan J. Lezhava, John W. Gorechlad, John D. Roback, Christopher D. Hillyer, Stephen Mittelstaedt, Mohammad S. Hossain, Sohel Talib, Edmund K. Waller
Publikováno v:
The Journal of Immunology. 171:6023-6031
Infusion of donor antiviral T cells can provide protective immunity for recipients of hemopoietic progenitor cell transplants, but may cause graft-vs-host disease (GVHD). Current methods of separating antiviral T cells from the alloreactive T cells t
Autor:
John D. Roback, Levan J. Lezhava, Leon Su, Christopher D. Hillyer, James L. Newman, Natia Saakadze
Publikováno v:
Transfusion. 46(6)
BACKGROUND: Donor and recipient mechanisms that modulate the incidence and severity of transfusion-transmitted cytomegalovirus (TT-CMV) are unclear. The kinetics of murine CMV (MCMV) infection in the peripheral blood of donor mice were investigated t
Autor:
Cetherine T, Jordan, Natia, Saakadze, James L, Newman, Levan J, Lezhava, Tanya T, Maiers, Whitney M, Hillyer, John D, Roback, Christopher D, Hillyer
Publikováno v:
Transfusion. 44(8)
A photochemical treatment (PCT) process utilizing amotosalen hydrochloride and long wavelength UVA light has been developed to inactivate pathogens in PLTs. This study investigated the effects of amotosalen/UVA treatment on free and latent murine CMV
Autor:
William S. Luckett, Christopher D. Hillyer, Levan J. Lezhava, Thomas W. Dubensky, John D. Roback, Martin Giedlin
Publikováno v:
Blood. 106:575-575
Background: We previously described a live-attenuated (L/A) Listeria monocytogenes (Lm)-based vaccine encoding murine CMV (MCMV) epitopes (Lm-MCMV) that effectively drives expansion of antiviral CD8+ T-cells in wild-type mice and following bone marro
Autor:
William S. Luckett, John D. Roback, Elisabeth Hesse, Thomas W. Dubensky, Christopher D. Hillyer, Martin A. Giedlin, Levan J. Lezhava
Publikováno v:
Blood. 104:2129-2129
Background : Recipients of hematopoietic stem cell transplantation (HSCT) can be severely immunocompromised, predisposing to opportunistic infections including cytomegalovirus (CMV). While adoptive transfer of ex vivo expanded donor antiviral T-cells
Autor:
Christopher D. Hillyer, John D. Roback, Mohammad S. Hossain, Edmund K. Waller, Levan J. Lezhava
Publikováno v:
Biology of Blood and Marrow Transplantation. (3):169-180
We have previously shown that amotosalen HCl (S-59 psoralen)-treated donor splenocytes, which have limited proliferative capacity in vitro, can protect major histocompatibility complex-mismatched bone marrow transplant (BMT) recipients from lethal mu